Cost-Effectiveness Modeling in the Pharmaceutical Industry

blended course

The purpose of this seminar is to provide the theoretical background as well as ample applications/illustrations and practical work on cost-effectiveness methodology and modelling. Cost-effectiveness - as part of health economics/pharmacoeconomics - is becoming increasingly important in the reimbursement of new drugs, introduction of new vaccines, allowing new medical devices and designing large-scale prevention programs. Cost-effectiveness logically relates the costs with downstream savings within (reduced health-care expenditures) as well as outside of the healthcare sector (such as productivity effects), on the one hand, with outcomes on the other hand, that can be clinically oriented (cases avoided) or at a more abstract level (quality-adjusted life years; QALYs).

Course leader

PROF. MAARTEN POSTMA, UNIVERSITY OF GRONINGEN, THE NETHERLANDS

Target group

Advanced undergraduates, graduates, and faculty in economics and pharmacy schools

Course aim

To enhance expertise on this subject

Credits info

1.5 EC
Credits can be earned with prior approval of the student's school

Fee info

USD 1500: Includes lecture attendance, room and board, excursion, and reading material
EUR 500: Includes lecture attendance and reading material

Scholarships

Yes (to low-income Greek students)